Apoptosis: Molecular aspects of cell death and disease

Laboratory Investigation

Volumn 78, Issue 8, 1998, Pages 893-913

  Granville, David J ^a,b   Carthy, Chris M ^a,b   Hunt, David W C ^a,b   McManus, Bruce M ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b QLT PhotoTherapeutics Inc   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BCL 2;

AGING; APOPTOSIS; CARCINOGENESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTIVITY;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CELLS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; NECROSIS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEURODEGENERATIVE DISEASES; VIRUS DISEASES;

EID: 0031870774     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (209)

1. Abu-Amer Y and Tondravi M (1997). NF-κB and bone: The breaking point. Nat Med 3:1189-1190.
2. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, and Nagata S (1995). Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Clin Exp Pharmacol Physiol 22:861-863.
3. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, and Alnemri ES (1997). CRADD, a novel human apoptotic adaptor molecule for caspase-2, and Fas-L/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 57:615-619.
4. Ahmed MM, Sells SF, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Harp C, Mohiuddin M, and Rangnekar VM (1997). Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1. J Biol Chem 272:33056-33061.
5. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen S, Thornberry NA, Wong WW, and Yuan J (1996). Human ICE/CED-3 protease nomenclature. Cell 87:171.
6. Ambrosini G, Adida C, and Altieri DC (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921.
7. Baeuerle PA and Baltimore D (1996). NF-κB: Ten years after. Cell 87:13-20.
8. Ballou LR, Laulederkind SJ, Rosloniec EF, and Raghow R (1996). Ceramide signalling and the immune response. Cancer Res 56:2711-2714.
9. Barkett M, Xue D, Horvitz HR, and Gilmore TD (1997). Phosphorylation of IκB-α inhibits its cleavage by caspase CPP32 in vitro. J Biol Chem 272:29419-29422.
10. Beg AA and Baltimore D (1996). An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274:782-784.
11. Berlin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, Wang GH, Senkevich TG, Alnemri ES, Moss B, Lenardo MJ, Tomaselli KJ, and Cohen JI (1997). Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci U S A 94:1172-1176.
12. Bosman FT, Visser BC, and van Oeveren J (1996). Apoptosis: Pathophysiology of programmed cell death. Pathol Res Pract 192:676-683.
13. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, and Chinnaduria G (1995). Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11:1921-1928.
14. Brown J, Higo H, McKalip A, and Herman B (1997). Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: Role of p53, ICE-like proteases and the mitochondrial permeability transition. J Cell Biochem 66: 245-255.
15. Burek MJ and Oppenheim RW (1996). Programmed cell death in the developing nervous system. Brain Pathol 6:427-446.
16. Cai W, Devaux B, Schaper W, and Schaper J (1997). The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 131:177-186.
17. Cardone MH, Salvesen GS, Widmann C, Johnson G, and Frisch SM (1997). The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90:315-323.
18. Carraro U and Franceschi C (1997). Apoptosis of skeletal and cardiac muscles and physical exercise. Aging (Milano) 9:19-34.
19. Casciola-Rosen L, Nicholson DW, Chong T, Rowan K, Thornberry NA, Miller D, and Rosen A (1996). Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J Exp Med 183: 1957-1964.
20. Caulin C, Salvesen GS, and Oshima RG (1997). Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138: 1379-1394.
21. L and Bcl-2 repress a common pathway of cell death. J Exp Med 182:821-828.
22. Chen L, Marechal V, Moreau J, Levine AJ, and Chen J (1997). Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J Biol Chem 272:22966-22973.
23. Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS, and Hardwick JM (1997). A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpes-virus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 94:690-694.
24. Chinnaiyan AM, O'Rourke K, Lane BR, and Dixit VM (1997). Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 275:1122-1126.
25. Chiou SK, Tseng CC, Rao L, and White E (1994). Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J Virol 68:6553-6566.
26. Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, and Levrero M (1997). The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci U S A 94:8162-8167.
27. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, and Ballard DW (1997). Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis C-IAP2 is under NF-κB control. Proc Natl Acad Sci U S A 94:10057-10062.
28. Connelly MA and Marcu KB (1995). CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain. Cell Mol Biol Res 41:537-549.
29. Conzen SD, Snay CA, and Cole CN (1997). Identification of a novel antiapoptotic functional domain in simian virus 40 large T antigen. J Virol 71:4536-4543.
30. Cosulich SC, Horiuchi H, Zerial M, Clarke PR, and Woodman PG (1997). Cleavage of rabaptin-5 blocks endosome fusion during apoptosis. EMBO J 16:6182-6191.
31. Cryns VL, Bergeron L, Zhu H, Li H, and Yuan J (1996). Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1 beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J Biol Chem 271:31277-31282.
32. Cuff S and Ruby J (1996). Evasion of apoptosis by DNA viruses. Immunol Cell Biol 4:527-537.
33. Cui H, Matsui K, Omura S, Schauer SL, Matulka RA, Sonenshein GE, and Ju ST (1997). Proteasome regulation of activation-induced T cell death. Proc Natl Acad Sci U S A 94:7515-7520.
34. Davies MJ (1997). Apoptosis in cardiovascular disease. Heart 77:498-501.
35. Dbaibo GS (1997). Regulation of the stress response by ceramide. Biochem Soc Trans 25:557-561.
36. Desmouliere A, Badid C, Bochaton-Piallat ML, and Gabbiani G (1997). Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol 29:19-30.
37. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, and Karin M (1997). A cytokine-responsive IkB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
38. Driscoll M (1996). Cell death in C. elegans: Molecular insights into mechanisms conserved between nematodes and mammals. Brain Pathol 6:411-425.
39. Duan H and Dixit VM (1997). RAIDD is a new "death" adaptor molecule. Nature 385:86-89.
40. Eguchi Y, Shimizu S, and Tsujimoto Y (1997). Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57:1835-1840.
41. Ellis HM and Horvitz HR (1986). Genetic control of programmed cell death in the nematode C. elegans. Cell 44:817-829.
42. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, and Nagata S (1998). A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50.
43. Enari M, Talanian RV, Wong WW, and Nagata S (1996). Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723-726.
44. Farber JL and El-Mofty SK (1975). The biochemical pathology of liver cell necrosis. Am J Pathol 81:237-250.
45. Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC, and Brown R (1995). Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731-733.
46. Fekete DM, Homburger SA, Waring MT, Riedl AE, and Garcia LF (1997). Involvement of programmed cell death in morphogenesis of the vertebrate inner ear. Development 124:2451-2461.
47. Flemming W (1885). Über die Bildung von Richtungsfiguren in Säugethiereiern beim Untertang Graaf'scher Follikel. Arch Anat EntwGesch, 221-224.
48. French LE and Tschopp J (1996). Constitutive Fas ligand expression in several non-lymphoid mouse tissues: Implications for immune-protection and cell turnover. Behring Inst Mitt 97:156-160.
49. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME, and Debatin KM (1997). Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 57:4956-4964.
50. Gajewski TF and Thompson CB (1996). Apoptosis meets signal transduction: Elimination of a BAD influence. Cell 87:589-593.
51. Gelbard HA, Boustany RM, and Schor NF (1997). Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease. Pediatr Neurol 16:93-97.
52. Geley S, Hartmann BL, and Kofler R (1997). Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA. FEBS Lett 400:15-18.
53. Glucksmann A (1951). Cell death in normal vertebrate ontology. Biol Rev 26:59-86.
54. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, and Wallach D (1997). CASH, a novel caspase homologue with death effector domains. J Biol Chem 272: 19641-19644.
55. Granville DJ, Carthy CM, Yang D, Hunt DWC, and McManus BM (in press, 1998a). Interactions of viral proteins with host cell death machinery. Cell Death Differ.
56. Granville DJ, Jiang H, An MT, Levy JG, McManus BM, and Hunt DW (1998b). Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA. FEBS Lett 422:151-154.
57. Granville DJ, Levy JG, and Hunt DW (1997). Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death Differ 4:623-629.
58. Gregoli PA and Bondurant MC (1997). The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. Blood 90:630-640.
59. Gupta S (1996). Apoptosis/programmed cell death: A historical perspective. Adv Exp Med Biol 406:1-9.
60. Haanen C and Vermes I (1996). Apoptosis: Programmed cell death in fetal development. Eur J Obstet Gynecol Reprod Biol 64:129-133.
61. Hajnoczky G, Robb-Gaspers LD, Seitz MB, and Thomas AP (1995). Decoding of cytosolic calcium oscillations in the mitochondria. Cell 82:415-424.
62. Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L, and Williams LT (1998). CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr Biol 8:537-540.
63. Hannun YA (1997). Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845-1853.
64. Hardwick JM (1997). Virus-induced apoptosis. In: Kaufmann SH, editor: Apoptosis: Pharmacological implications and therapeutic opportunities. San Diego: Academic Press Ltd., 295-336.
65. Harris CC and Hollstein M (1993). Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327.
66. Hawkins HK, Ericsson JL, Biberfeld P, and Trump BF (1972). Lysosome and phagosome stability in lethal cell injury. Morphologic tracer studies in cell injury due to inhibition of energy metabolism, immune cytolysis and photosensitization. Am J Pathol 68:255-258.
67. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, and Rickinson A (1993). Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A 90:8479-8483.
68. Hentgartner M, Ellis RE, and Horvitz HR (1992). Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356:494-499.
69. Hentgartner MO and Horvitz HR (1994). C. elegans cell survival gene ced-9 encode a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665-676.
70. - T cells with aging. Mech Aging Dev 94:123-134.
71. Herr I, Wilhelm D, Bohler T, Angel P, and Debatin KM (1997). Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 16:6200-6208.
72. Herrmann JL, Bruckheimer E, and McDonnell TJ (1996). Cell death signal transduction and Bcl-2 function. Biochim Biophys Acta 1314:147-156.
73. Herrmann JL, Menter DG, Beham A, von Eschenbach A, and McDonnell TJ (1997). Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp Cell Res 234:442-451.
74. Hofmann K, Bucher P, and Tschopp J (1997). The CARD domain: A new apoptotic signalling motif. Trends Biochem Sci 257:155-156.
75. Hu S, Vincenz C, Buller M, and Dixit VM (1997a). A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J Biol Chem 272:9621-9624.
76. Hu S, Vincenz C, Ni J, Gentz R, and Dixit VM (1997b). I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 272:17255-17257.
77. L inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res 56: 4743-4748.
78. Ibrado AM, Liu L, and Bhalla K (1997). Bcl-XL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res 57:1109-1115.
79. lotsova V, Caamano J, Loy J, Yang Y, Lewin A, and Bravo R (1997). Osteoporosis in mice lacking NF-κB1 and NF-κB2. Nat Med 3:1285-1289.
80. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, and Tschopp J (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195.
81. Jacobson MD, Weil M, and Raff MC (1997). Programmed cell death in animal development. Cell 88:347-354.
82. James TN (1994). Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. J Mol Cell Cardiol 26:943-948.
83. Jelkmann W and Metzen E (1996). Erythropoietin in the control of red cell production. Anat Anz 178:391-403.
84. Jouaville LS, Ichas F, Holmuhamedov EL, Camacho P, and Lechleiter JD (1995). Synchronization of calcium waves by mitochondrial substrates in Xenopus laevis oocytes. Nature 377:438-441.
85. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed, JC, Quaini F, Sonnenblick EH, and Anversa P (1995). Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Arkh Patol 57:51-56.
86. Kamada SM, Washida M, Hasegawa J, Kusano H, Funahashi Y, and Tsujimoto Y (1997). Involvement of caspase-4(-like) protease in Fas-mediated apoptotic pathway. Oncogene 15:285-290.
87. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, and Kumegawa M (1997). Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186:489-495.
88. Kane DJ, Ord T, Anton R, and Bredesen DE (1995). Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res 40:269-275.
89. Kayalar C, Ord T, Testa MP, Zhong LT, and Bredesen DE (1996). Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci U S A 93:2234-2238.
90. Kerr JF (1965). A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J Pathol Bacteriol 90:419-435.
91. Kerr JF (1969). An electron-microscope study of liver cell necrosis due to heliotrine. J Pathol 97:557-562.
92. Kerr JF (1971). Shrinkage necrosis: A distinct mode of cellular death. J Pathol 105:13-20.
93. Kerr JFR, Wyllie AH, and Currie AR (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-245.
94. Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S, Weichselbaum R, Nalin C, and Kufe D (1997). Role for Bcl-XL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A 94:6939-6942.
95. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD (1997). The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
96. Kolesnick RN, Haimovitz-Friedman A, and Fuks Z (1994). The sphingomyelin signal transduction pathway mediates apo ptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol 72:471-474.
97. Kolesnick RN and Kronke M (1998). Regulation of ceramide production and apoptosis. Annu Rev Physiol 60:643-665.
98. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, and Williams LT (1997). Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 278:294-298.
99. Koury MJ, Home DW, Brown ZA, Pietenpol JA, Blount BC, Ames BN, Hard R, and Koury ST (1997). Apoptosis of late-stage erythroblasts in megaloblastic anemia: Association with DNA damage and macrocyte production. Blood 89:4617-4623.
100. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, and Reed JC (1993). Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714.
101. Kroemer G (1997). The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614-620.
102. Kroemer G, Zamzami N, and Susin SA (1997). Mitochondrial control of apoptosis. Immunol Today 18:44-51.
103. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, and Flavell RA (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-372.
104. Leist M, Single B, Castoldi AF, Kuhnle S, and Nicotera P (1997). Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 185:1481-1486.
105. Li H, Lochmuller H, Yong VW, Karpati G, and Nalbantoglu J (1997a). Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status. J Neuropathol Exp Neurol 56:872-878.
106. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, and Wang X (1997b). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489.
107. Limbourg FP, Stadtler H, Chinnadurai G, Baeuerle PA, and Schmitz ML (1996). A hydrophobic region within the adenovirus E1B 19 kDa protein is necessary for the transient inhibition of NF-κB activated by different stimuli. J Biol Chem 271:20392-20398.
108. Liu X, Zou H, Slaughter C, and Wang X (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184.
109. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, and Jacks T (1994). p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810.
110. MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, and Alnemri ES (1997). Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 272:25417-25420.
111. Majno G and Joris I (1995). Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15.
112. Malinin NL, Boldin MP, Kovalenko AV, and Wallach D (1997). MAPSK-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540-544.
113. Mallat Z, Ohan J, Leseche G, and Tedgui A (1997). Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation 96:424-428.
114. Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, Casciola-Rosen LA, and Rosen A (1998). The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling. J Cell Biol 140:1485-1495.
115. Manolagas SC and Jilka RL (1995). Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311.
116. Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, and Ashkenazi A (1997). A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 7:1003-1006.
117. Martin S and Green D (1995). Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349-352.
118. Matsuyama S, Xu Q, Velours J, and Reed JC (1998). The mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1:327-336.
119. McGill G (1997). Apoptosis in tumorigenesis and cancer therapy. Front Biosci 2:D353-D379.
120. Mizushima N, Koike R, Kohsaka H, Kushi Y, Handa S, Yagita H, and Miyasaka N (1996). Ceramide induces apoptosis via CPP32 activation. Nature 383:716-719.
121. Mori C, Nakamura N, Kimura S, Irie H, Takigawa T, and Shiota K (1995). Programmed cell death in the interdigital tissue of the fetal mouse limb is apoptosis with DNA fragmentation. Anat Rec 242:103-110.
122. Nagata S (1997). Apoptosis by death factor. Cell 88:355-365.
123. Nagata S (1996). Fas-mediated apoptosis. Adv Exp Med Biol 406:119-124.
124. Narayanan S (1996). Laboratory markers as an index of aging. Ann Clin Lab Sci 26:50-59.
125. Neamati N, Fernandez A, Wright S, Kiefer J, and McConkey DJ (1995). Degradation of Lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J Immunol 154:3788-3795.
126. Ng FWH, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA, and Shore GC (1997). p28 bap31, a bcl-2/Bcl-XI- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol 139:327-338.
127. Nicholson DW and Thornberry NA (1997). Caspases: Killer proteases. Trends Biochem Sci 22:299-306.
128. Nicholson WD, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, and Lazebnik YA (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43.
129. Obeid LM, and Hannun YA (1995). Ceramide: A stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 58:191-198.
130. Okisaka S, Murakami A, Mizukawa A, and Ito J (1997). Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes. Jpn J Ophthalmol 41:84-88.
131. Otterbach B and Stoffel W (1995). Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81: 1053-1061.
132. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, and Dixit VM (1997a). The receptor for the cytotoxic ligand TRAIL. Science 276:111-113.
133. Pan G, O'Rourke K, and Dixit VM (1998a). Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem 273:5841-5845.
134. Pan G, Ni J, Wei YF, Yu G, Gentz R, and Dixit VM (1997b). An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818.
135. Pan G, Ni J, Yu G, Wei YF, and Dixit VM (1998b). TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett 424:41-45.
136. Pegoraro L, Palumbo A, Erikson J, Falda M, Giovanazzo B, Emanuel BS, Rovero G, Nowell PC, and Croce CM (1984). A 14;18 and a 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci U S A 81:7166-7170.
137. Pena LA, Fuks Z, and Kolesnick R (1997). Stress-induced apoptosis and the sphingomyelin pathway. J Biol Chem 272:6918-6926.
138. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, and Ashkenazi A (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690.
139. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, and White E (1992). The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A 89:7742-7746.
140. Reed JC (1996). Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt 97:72-100.
141. Reed JC (1997). Double identity for proteins of the Bcl-2 family. Nature 387:773-776.
142. Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S, and Hanada M (1996). BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60:23-32.
143. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, and Rothe M (1997). Identification and characterization of an IkappaB kinase. Cell 90:373-383.
144. Rowan S and Fisher DE (1997). Mechanisms of apoptotic cell death. Leukemia 11:457-465.
145. Roy N, Deveraux QL, Takahashi R, Salvesen GS, and Reed JC (1997). The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16:6914-6925.
146. Rudin CM and Thompson CB (1997). Apoptosis and disease: Regulation and clinical relevance of programmed cell death. Annu Rev Med 48:267-281.
147. Sakahira H, Enari M, and Nagata S (1998). Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96-99.
148. Salvesen GS, and Dixit VM (1997). Caspases: Intracellular signaling by proteolysis. Cell 91:443-446.
149. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, and Kolesnick R (1996). Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. J Exp Med 184:549-555.
150. Schwartzman RA and Cidlowski JA (1993). Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 14:133-151.
151. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, and Ashkenazi A (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821.
152. Shimizu S, Eguchi Y, Kamiike W, Funahashi Y, Mignon A, Lacronique V, Matsuda H, and Tsujimoto Y (1998). Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci U S A 95:1455-1459.
153. Shimizu S, Eguchi Y, Kosaka H, Kamuke W, Matsuda H, and Tsujimoto Y (1995). Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-XL. Nature 374:811-813.
154. Shisler J, Yang C, Walter B, Ware CF, and Gooding LR (1997). The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J Virol 71:8299-8306.
155. Shu HB, Halpin DR, and Goeddel DV (1997). Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6:751-763.
156. Simonati A, Rosso T, and Rizzuto N (1997). DNA fragmentation in normal development of the human central nervous system: A morphological study during corticogenesis. Neuropathol Appl Neurobiol 23:203-211.
157. Smith SC, Baker PN, and Symonds EM (1997). Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol 177:57-65.
158. Snell V, Clodi K, Zhao S, Goodwin R, Thomas EK, Morris SW, Kadin ME, Cabanillas F, Andreeff M, and Younes A (1997). Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br J Haematol 99:618-624.
159. Song HY, Regnier CH, Kirschning CJ, Goeddel DV, and Rothe M (1997). Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci U S A 94:9792-9796.
160. Spencer SJ, Cataldo NA, and Jaffe RB (1996). Apoptosis in the human female reproductive tract. Obstet Gynecol Surv 51:314-323.
161. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, and Alnemri ES (1996). Molecular ordering of the Fasapoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci U S A 93:14486-14491.
162. Srinivasula SM, Ahmad M, Ottilie S, Bullrich F, Banks S, Wang Y, Fernandes-Alnemri T, Croce CM, Litwack G, Tomaselli KJ, Armstrong RC, and Alnemri ES (1997). FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem 272:18542-18545.
163. Stellar H (1995). Mechanisms and genes of cellular suicide. Science 267:1445-1449.
164. Sulston JF and Horvitz HR (1977). Post-embryonic cell lineages of the nematode Caenorhabditis elegans. Dev Biol 56:110-156.
165. Sun DY, Jiang S, Zheng LM, Ojcius DM, and Young JD (1994). Separate metabolic pathways leading to DNA fragmentation and apoptotic chromatin condensation. J Exp Med 179:559-568.
166. Takahashi A, Alnemri ES, Lazebnik YA, Fernandes-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirier GG, Kaufmann SH, and Earnshaw WC (1996). Cleavage of lamin A by Mch2a but not CPP32: Multiple interleukin 1b-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci U S A 93:8395-8400.
167. Talanian RV, Yang X, Turbov J, Seth P, Ghayur T, Casiano CA, Orth K, and Froelich CJ (1997). Granule-mediated killing: Pathways for granzyme B-initiated apoptosis. J Exp Med 186:1323-1331.
168. Tan X, Martin SJ, Green DR, and Wang JYJ (1997). Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem 272:9613-9616.
169. Teodoro J and Branton P (1997). Regulation of apoptosis by viral gene products. J Virol 71:1739-1746.
170. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer J, Schroter M, Scaffidi C, Krammer P, Peter ME, and Tschopp J (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521.
171. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1461.
172. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, and Nicholson DW (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272:17907-17911.
173. Tollefson AE, Ryerse JS, Scaria A, Hermiston TW, and Wold WS (1996a). The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: Characterization of cells infected with adp mutants. Virology 220:152-162.
174. Tollefson AE, Scaria A, Hermiston TW, Ryerse JS, Wold LJ, and Wold WS (1996b). The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J Virol 70:2296-2306.
175. Tollefson AE, Scaria A, Saha SK, and Wold WS (1992). The 11:600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection. J Virol 66:3633-3642.
176. Tomkinson A, Reeve J, Shaw RW, and Noble BS (1997). The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 3128-3135.
177. Tsujimoto Y, Cossman J, Jaffe E, and Croce CM (1985). Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443.
178. Tufariello JM, Cho S, and Horwitz MS (1994). Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice. Proc Natl Acad Sci U S A 91:10987-10991.
179. Uchiyama Y (1995). Apoptosis: The history and trends of its studies. Arch Histol Cytol 58:127-137.
180. Usami S, Takumi Y, Fujita S, Shinkawa H, and Hosokawa M (1997). Cell death in the inner ear associated with aging is apoptosis? Brain Res 747:147-150.
181. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, and Verma IM (1996). Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
182. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, and Thompson CB (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627-637.
183. Vaux DL, Weissman IL, and Kim SK (1992). Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258:1955-1957.
184. Virchow R (1858). Cellular pathology. As based upon physiological and pathological histology. Lecture VI-Atheromatous affection of arteries. Nutr Rev 47:23-25.
185. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, and Rauch CT (1997). TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J 16: 5386-5397.
186. Wang CY, Mayo MW, and Baldwin ASJ (1996a). TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784-787.
187. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, and Goldstein JL (1996b). Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 15:1012-1020.
188. Warner HR (1997). Aging and regulation of apoptosis. Curr Top Cell Regul 35:107-121.
189. Warner HR, Hodes RJ, and Pocinki K (1997). What does cell death have to do with aging? J Am Geriatr Soc 45:1140-1146.
190. Wattre P, Bert V, and Hober D (1996). Apoptosis and human viral infections. Ann Biol Clin (Paris) 54:189-197.
191. Wen LP, Fahrni JA, Troie S, Guan JL, Orth K, and Rosen GD (1997). Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem 272:26056-26061.
192. White E, Cipriani R, Sabbatini P, and Denton A (1991). Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J Virol 65:2968-2978.
193. Widmann C, Gibson S, and Johnson GL (1998). Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 273:7141-7147.
194. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, and Smith CA (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682.
195. Wyllie A (1998). An endonuclease at last. Nature 391:20-21.
196. Wyllie AH (1987). Apoptosis: Cell death in tissue regulation. J Pathol 153:313-136.
197. Wyllie AH, Beattie GJ, and Hargreaves AD (1981). Chromatin changes in apoptosis. Histochem J 13:681-692.
198. Xu Q and Reed JC (1998). Bax Inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell 1:337-346.
199. Yanagisawa J, Takahashi M, Kanki H, Yano-Yanagisawa H, Tazunoki T, Sawa E, Nishitoba T, Kamishohara M, Kobayashi E, Kataoka S, and Sato T (1997). The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J Biol Chem 272:8539-8545.
200. Yang E, Zha J, Jockel J, Boise L, Thompson CB, and Korsemeyer SJ (1995). Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291.
201. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T, Jones DP, and Wang X (1997). Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132.
202. Yew PR, Liu X, and Berk AJ (1994). Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev 8:190-202.
203. Yuan J (1996). Evolutionary conservation of a genetic pathway of programmed cell death. J Cell Biochem 60:4-11.
204. Yuan J (1997). Transducing signals of life and death. Curr Opin Cell Biol 9:247-251.
205. Yuan J and Horvitz HR (1992). The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 116:309-320.
206. Yuan J, Shaham S, Ledoux S, Ellis HM, and Horvitz HR (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641-652.
207. Zhang J, Alter N, Reed JC, Borner C, Obeid LM, and Hannun YA (1996). Bcl-2 interrupts the ceramide-mediated pathway of cell death. J Biol Chem 271:13094-13102.
208. Zou H, Henzel WJ, Liu X, Lutschg A, and Wang X (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.
209. Zumbansen M and Stoffel W (1997). Tumor necrosis factor-α activates NF-κB in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J Biol Chem 272:10904-10909.